Next Article in Journal
Factors Associated with Time to Sarcoma Diagnosis: Results from a Global Cross-Sectional Survey by the Sarcoma Patient Advocacy Global Network (SPAGN)
Previous Article in Journal
Liver Transplantation as a Salvage Therapy Option in Colorectal Liver Metastases: Feasibility, Oncologic Outcomes, and Survival After Failure of Conventional Therapy—A Systematic Review and Meta-Analysis
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cancers
Volume 18
Issue 8
10.3390/cancers18081255
cancers-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Correction to Cancers 2025, 17(6), 939.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Nguyen et al. Prognostic Significance of Key Molecular Markers in Thyroid Cancer: A Systematic Literature Review and Meta-Analysis. Cancers 2025, 17, 939

by
Linh T. T. Nguyen
1,2,
Emma K. Thompson
3,
Nazim Bhimani
3,4,
Minh C. Duong
5,
Huy G. Nguyen
6,
Martyn Bullock
1,
Matti L. Gild
1,7 and
Anthony Glover
1,3,4,*
1
Kolling Institute, Northern Sydney Local Health District and Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW 2050, Australia
2
Department of Endocrinology, The 108 Military Central Hospital, Hanoi 100000, Vietnam
3
The Kinghorn Cancer Centre, Garvan Institute of Medical Research, St. Vincent’s Clinical School, Faculty of Medicine, University of New South Wales, Darlinghurst, NSW 2010, Australia
4
Specialty of Surgery, Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW 2050, Australia
5
School of Population Health, University of New South Wales, Sydney, NSW 2033, Australia
6
School of Biomedical Engineering, University of Technology Sydney, Sydney, NSW 2007, Australia
7
Department of Endocrinology, Royal North Shore Hospital, Northern Sydney Local Health District, Sydney, NSW 2065, Australia
*
Author to whom correspondence should be addressed.
Cancers 2026, 18(8), 1255; https://doi.org/10.3390/cancers18081255
Submission received: 13 April 2026 / Accepted: 14 April 2026 / Published: 16 April 2026
Browse Figure
Versions Notes
Error in Figure
In the original publication [1], there was a mistake in Figure 1, “Selection and screening process for included studies from three databases”, as published.
  • At the Identification step, 20 documents from sources other than the three databases were all manually excluded. This step is added to one branch of the flowchart to accurately reflect the process.
  • At the Eligibility assessment step, the number of studies excluded was 123, not 107. This correction does not affect the final number of studies included, which remains 9.
The corrected Figure 1 appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Nguyen, L.T.T.; Thompson, E.K.; Bhimani, N.; Duong, M.C.; Nguyen, H.G.; Bullock, M.; Gild, M.L.; Glover, A. Prognostic Significance of Key Molecular Markers in Thyroid Cancer: A Systematic Literature Review and Meta-Analysis. Cancers 2025, 17, 939. [Google Scholar] [CrossRef] [PubMed]
Cancers 18 01255 g001
Figure 1. Selection and screening process for included studies from three databases.
Figure 1. Selection and screening process for included studies from three databases.
Cancers 18 01255 g001
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Nguyen, L.T.T.; Thompson, E.K.; Bhimani, N.; Duong, M.C.; Nguyen, H.G.; Bullock, M.; Gild, M.L.; Glover, A. Correction: Nguyen et al. Prognostic Significance of Key Molecular Markers in Thyroid Cancer: A Systematic Literature Review and Meta-Analysis. Cancers 2025, 17, 939. Cancers 2026, 18, 1255. https://doi.org/10.3390/cancers18081255

AMA Style

Nguyen LTT, Thompson EK, Bhimani N, Duong MC, Nguyen HG, Bullock M, Gild ML, Glover A. Correction: Nguyen et al. Prognostic Significance of Key Molecular Markers in Thyroid Cancer: A Systematic Literature Review and Meta-Analysis. Cancers 2025, 17, 939. Cancers. 2026; 18(8):1255. https://doi.org/10.3390/cancers18081255

Chicago/Turabian Style

Nguyen, Linh T. T., Emma K. Thompson, Nazim Bhimani, Minh C. Duong, Huy G. Nguyen, Martyn Bullock, Matti L. Gild, and Anthony Glover. 2026. "Correction: Nguyen et al. Prognostic Significance of Key Molecular Markers in Thyroid Cancer: A Systematic Literature Review and Meta-Analysis. Cancers 2025, 17, 939" Cancers 18, no. 8: 1255. https://doi.org/10.3390/cancers18081255

APA Style

Nguyen, L. T. T., Thompson, E. K., Bhimani, N., Duong, M. C., Nguyen, H. G., Bullock, M., Gild, M. L., & Glover, A. (2026). Correction: Nguyen et al. Prognostic Significance of Key Molecular Markers in Thyroid Cancer: A Systematic Literature Review and Meta-Analysis. Cancers 2025, 17, 939. Cancers, 18(8), 1255. https://doi.org/10.3390/cancers18081255

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop